Maintain core JPM exposure at ~$350 with gap-aware $342 stop; defer all sizing to Q3 catalyst
Hold core JPM at ~$350 with $342 gap-aware stop; do not trim into $358-$360 or add beyond core until Q3 earnings empirically resolves whether Petno's mid-to-high teens IB/markets guidance delivers clean or disappoints. The $33B buyback floor, 200 SMA at $318 providing 10% structural buffer, and $48.2B annualized capital return support holding core through the catalyst window.
| Position | Action |
|---|---|
| Current state | Maintain core JPM exposure at ~$350 |
| Core position in uptrend toward $358-$360 | Do NOT pre-commit to trimming on strength (avoid selling 17.8% ROE franchise during 4% pullback in favorable NIM regime) |
| $320 retest (longer-horizon) | Add to position at $320 |
| Q3 earnings mid-October | Resolve bull/bear dispute empirically; reassess all sizing rules |
The pullback to $349.67 is a textbook capitulation flush at the lower Bollinger Band that creates a high-probability entry ahead of Q3 beat-and-raise; JPM's 47% EPS growth, expanding NIM in higher-for-longer regime, $51.2B shareholder returns, and accelerating buybacks justify 2.63x P/B as rational rather than stretched.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 352.15 | bearish |
| 50 SMA | 353.20 | bearish |
| 200 SMA | 318.71 | bullish |
| RSI (14) | 44.47 | neutral |
| MACD Line | -0.86 | bearish |
| MACD Signal | +0.34 | bearish |
| MACD Histogram | -1.20 | bearish |
| Bollinger Upper Band (20) | 361.27 | neutral |
| Bollinger Middle Band (20 SMA) | 354.47 | neutral |
| Bollinger Lower Band (20) | 347.67 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price retests $320 longer-horizon support
Then: Add to position as longer-horizon entry
↩ rebuts: “Bear's fixation on 4.2% pullback as warning sign”
EV: +$50–$80 on Q3 beat-and-raise scenario; 12-month target $400+; TIKR 2030 framework implies $428 · concedes: Stock is below the 10-day EMA; MACD just crossed down; Current geopolitical tape is noisy; Doug Petno's Q3 guidance is for mid-to-high teens growth (not exceptional), and actual results have not yet printed; The dividend hike could theoretically be read as management responding to shareholder pressure rather than pure fundamentals; A close below $345 would flip the thesis and represent ~1.4% downside risk
JPM's headline strength obscures mounting credit cycle risks, valuation stretched on forward metrics, and a technically bearish setup—at current prices, the asymmetry favors sellers over buyers.
· concedes: JPM's 17.8% ROE is best-in-class and structurally superior to regional banks; JPM's diversified model means it survives credit downturns better than peers; Doug Petno's Q3 IB guidance is directionally accurate for one quarter; JPM's ALM and hedging capabilities may be best-in-class
→ vs conservative: PEG ratio framework is inappropriate for franchise-quality compounder banks—17.8% ROE versus 9-10% cost of equity makes 2.0x PEG a buy signal, not a concern; PEG is a tech-stock metric misapplied here
→ vs conservative: Q2 EPS 'inflation' from $4.39B special items is noise—underlying NII grew 10% YoY to $25.5B on record franchise earnings; no need to wait for 'clean' Q3 print
→ vs conservative: Higher rates are a tailwind, not a headwind—$4.6T earning asset base with prime at 7% generates massive NII expansion; Polymarket 95% zero cuts probability supports this regime
→ vs conservative: 'Buffer before adding' is contradictory—own analysis identified full bull thesis yet advocates inaction on 6-10:1 asymmetric setup
→ vs neutral: Low sentiment reading (6.2/10) is bullish—uncrowded positioning means vacuum move on Q3 catalyst rather than slow grind; no retail euphoria to unwind
| ATR (14) | 6.76 | neutral |
| VWMA (20) | 352.71 | bearish |
| Volume (09-18) | 18.24M | neutral |
| Price vs 200 SMA | +9.7% above | bullish |
Support: 347.67 · 345.07 · 343.07 · 330 | Resistance: 352.15 · 353.2 · 354.47 · 361.27 · 365.18
Technical analysis shows JPM in a corrective pullback phase within a long-term uptrend. Price ($349.67) sits above the 200 SMA (318.71) maintaining bullish long-term structure, but trades below both the 10 EMA (352.15) and 50 SMA (353.20) with a bearish MACD crossover (histogram -1.20), indicating short-term momentum deterioration. RSI at 44.47 shows mild bullish divergence as it did not make a new low during the recent pullback. The September 18 session produced an elevated volume spike of 18.24M shares as price tested the lower Bollinger Band at $347.67, with a close at the daily high—a potential capitulation pattern. Key support zones are $347.67 (BB lower), $345.07 (intraday low), and $330 (July consolidation); resistance clusters at $352–$354.47 and $361.27 (BB upper). The tactical bias favors a bounce attempt from current levels, but requires confirmation via a reversal candle at $345–$348 and a reclaim of $354.47 before committing to positions.
Market Cap
$929.5 billion
Stock Price (52-week range)
$279.10 – $366.50
50-Day Moving Average
$352.92
200-Day Moving Average
$320.33
Beta
0.975
Book Value per Share
$133.01
P/E (TTM)
14.99x
Forward P/E
13.99x
PEG Ratio
1.62
Price / Book
2.63x
Dividend Yield
1.72%
EPS (TTM)
$23.33
Forward EPS
$24.99
Revenue (TTM)
$186.33 billion
Net Income (TTM)
$63.63 billion
Profit Margin
34.9%
Operating Margin
50.4%
Return on Equity (ROE)
17.79%
Return on Assets (ROA)
1.36%
FY2025 Revenue
$181,847 million
FY2025 Net Income
$57,048 million
FY2025 Diluted EPS
$20.02
FY2025 Total Assets
$4,424.9 billion
FY2025 Net Loans
$1,467.7 billion
FY2025 Tangible Book Value
$277.9 billion
FY2025 Dividends Paid
$16,625 million
FY2025 Share Repurchases
$34,591 million
FY2024 Revenue
$169,439 million
FY2024 Net Income
$58,471 million
FY2024 Diluted EPS
$19.75
FY2023 Revenue
$154,952 million
FY2023 Net Income
$49,552 million
FY2023 Diluted EPS
$16.23
FY2022 Revenue
$127,727 million
FY2022 Net Income
$37,676 million
FY2022 Diluted EPS
$12.09
Q2 2026 Revenue
$52,852 million
Q2 2026 Net Income
$21,155 million
Q2 2026 Diluted EPS
$7.70
Q2 2026 NII
$25,511 million
Q2 2026 Total Assets
$5,015.1 billion
Q2 2026 Net Loans
$1,516.3 billion
Q2 2026 Tangible Book Value
$289.3 billion
Q1 2026 Revenue
$49,833 million
Q1 2026 Net Income
$16,494 million
Q1 2026 Diluted EPS
$5.94
H1 2026 Net Income
$37,649 million
Revenue 3Y CAGR
~12.5%
EPS 3Y CAGR
~18.4%
Total Shareholder Return 2025
$51.2 billion
Diluted Shares FY2025
2,781.5 million
Special/Unusual Items Q2 2026
$4,390 million
Strengths
Concerns
JPMorgan Chase & Co. is the largest U.S. bank holding company by assets ($5.02T as of Q2 2026) with four primary business segments generating diversified revenue streams. The bank delivered record Q2 2026 EPS of $7.70 with net income of $21.2 billion, representing 47% YoY growth, while FY2025 net income of $57.0B on revenue of $181.8B demonstrates sustained profitability with ROE of 17.79% (best-in-class for a G-SIB). The stock trades at a premium valuation (P/B 2.63x, forward P/E 13.99x) justified by its industry-leading returns, robust capital returns ($51.2B to shareholders in 2025), and strong book value growth, though trading near its 52-week high limits near-term upside without a catalyst. HOLD rating maintained; await Q3 2026 earnings or pullback to $325-$335 before adding positions.
Macro: Hawkish macro regime with Fed hiking and 95% Polymarket probability of ZERO rate cuts in 2026; 10Y Treasury near 5% (highest since 2007); active US-Iran conflict driving Brent crude above $100/bbl; 8% Polymarket recession probability suggests soft-landing/no-landing scenario. Dow and S&P 500 posting weekly losses with unfavorable bond-equity correlation.